HUTCHMED (China) Ltd (HCM)
16.75
-0.10
(-0.59%)
USD |
NASDAQ |
Nov 15, 16:00
16.75
0.00 (0.00%)
After-Hours: 19:54
HUTCHMED Enterprise Value: 2.171B for Nov. 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 14, 2024 | 2.171B |
| November 13, 2024 | 2.204B |
| November 12, 2024 | 2.279B |
| November 11, 2024 | 2.306B |
| November 08, 2024 | 2.359B |
| November 07, 2024 | 2.487B |
| November 06, 2024 | 2.424B |
| November 05, 2024 | 2.474B |
| November 04, 2024 | 2.433B |
| November 01, 2024 | 2.475B |
| October 31, 2024 | 2.368B |
| October 30, 2024 | 2.530B |
| October 29, 2024 | 2.641B |
| October 28, 2024 | 2.820B |
| October 25, 2024 | 2.855B |
| October 24, 2024 | 2.803B |
| October 23, 2024 | 2.940B |
| October 22, 2024 | 2.928B |
| October 21, 2024 | 2.855B |
| October 18, 2024 | 2.863B |
| October 17, 2024 | 2.610B |
| October 16, 2024 | 2.677B |
| October 15, 2024 | 2.506B |
| October 14, 2024 | 2.622B |
| October 11, 2024 | 2.622B |
| Date | Value |
|---|---|
| October 10, 2024 | 2.694B |
| October 09, 2024 | 2.723B |
| October 08, 2024 | 2.814B |
| October 07, 2024 | 2.873B |
| October 04, 2024 | 2.882B |
| October 03, 2024 | 2.701B |
| October 02, 2024 | 2.849B |
| October 01, 2024 | 2.709B |
| September 30, 2024 | 2.629B |
| September 27, 2024 | 2.545B |
| September 26, 2024 | 2.439B |
| September 25, 2024 | 2.280B |
| September 24, 2024 | 2.256B |
| September 23, 2024 | 2.111B |
| September 20, 2024 | 2.262B |
| September 19, 2024 | 2.164B |
| September 18, 2024 | 2.080B |
| September 17, 2024 | 2.077B |
| September 16, 2024 | 2.116B |
| September 13, 2024 | 2.246B |
| September 12, 2024 | 2.142B |
| September 11, 2024 | 2.164B |
| September 10, 2024 | 2.031B |
| September 09, 2024 | 2.246B |
| September 06, 2024 | 2.262B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
519.30M
Minimum
Oct 25 2022
6.526B
Maximum
Aug 09 2021
2.885B
Average
2.515B
Median
Jan 23 2023
Enterprise Value Benchmarks
| Takeda Pharmaceutical Co Ltd | 72.05B |
| AstraZeneca PLC | 226.96B |
| Sino Biopharmaceutical Ltd | 8.600B |
| Regencell Bioscience Holdings Ltd | 71.42M |
| Prenetics Global Ltd | 9.425M |
Enterprise Value Related Metrics
| Earnings Yield | -1.49% |
| Normalized Earnings Yield | -1.493 |